Acutus Medical
10840 Thornmint Road
San Diego
California
United States
Tel: 858-673-1621
Fax: 858-673-2274
Website: http://acutusmedical.com/
115 articles about Acutus Medical
-
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
4/1/2024
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today reported results for the fourth quarter and full year ended December 31,2023.
-
Acutus Medical to Cancel Third Quarter 2023 Conference Call
11/10/2023
Acutus Medical, Inc., announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November 8, 2023, the Company will no longer hold its third quarter results conference call and webcast which was previously scheduled for Monday, November 13, 2023.
-
Acutus Medical Reports Third Quarter 2023 Financial Results
11/8/2023
Acutus Medical, Inc. reported results for the third quarter of 2023.
-
Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring
11/8/2023
Acutus Medical, Inc., announced a realignment of resources and corporate restructuring.
-
Acutus Medical to Announce Third Quarter 2023 Financial Results
11/2/2023
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial results on Monday, November 13, 2023.
-
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 02, 2023
11/2/2023
Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on November 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 5 individuals hired by Acutus in October 2023.
-
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 02, 2023
10/2/2023
Acutus Medical, Inc. granted equity awards on October 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in September 2023.
-
Acutus Medical Reports Second Quarter 2023 Financial Results
8/7/2023
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the second quarter of 2023.
-
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 01, 2023
8/1/2023
Acutus Medical, Inc. granted equity awards on August 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in July 2023.
-
Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
7/27/2023
Acutus Medical, Inc. announced today that its management team will present at the 43rd Annual Canaccord Growth Conference on Thursday, August 10, 2023 at 9:30 a.m. Eastern Time at the InterContinental Boston Hotel in Boston, MA.
-
Acutus Medical to Announce Second Quarter 2023 Financial Results
7/24/2023
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its second quarter 2023 financial results on Monday, August 7, 2023.
-
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 03, 2023
7/3/2023
Acutus Medical, Inc. granted equity awards on July 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in June 2023.
-
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 01, 2023
6/1/2023
Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in May 2023.
-
Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023
5/15/2023
Acutus Medical, Inc. is pleased to announce its participation in the upcoming Heart Rhythm Society (HRS) Annual Scientific Sessions in New Orleans, LA from May 19-21, 2023.
-
Acutus Medical Reports First Quarter 2023 Financial Results
5/11/2023
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2023.
-
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 02, 2023
5/2/2023
Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on May 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 8 individuals hired by Acutus in April 2023.
-
Acutus Medical to Announce First Quarter 2023 Financial Results
4/28/2023
Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced that it will release its first quarter 2023 financial results on Thursday, May 11, 2023.
-
RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy
4/20/2023
Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced results from the RECOVER AF study.
-
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
4/20/2023
Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the first quarter 2023 in addition to the release of the RECOVER AF study data (published online in EP Europace)1.
-
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 03, 2023
4/3/2023
Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on April 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 7 individuals hired by Acutus in March 2023.